[Form 4] Monopar Therapeutics Inc. Insider Trading Activity

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

4

Rhea-AI Filing Summary

Analyzing...

Insights

Analyzing...

07/16/2025 - 09:03 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Monopar Therapeutics Inc

NASDAQ:MNPR

MNPR Rankings

#5188 Ranked by Market Cap

N/A Ranked by Dividends

MNPR Latest News

Jun 11, 2025

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

Jun 3, 2025

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

May 13, 2025

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

May 7, 2025

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

Apr 29, 2025

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

MNPR Latest SEC Filings

Jul 16, 2025

[Form 4] Monopar Therapeutics Inc. Insider Trading Activity

Jul 16, 2025

[Form 4] Monopar Therapeutics Inc. Insider Trading Activity

Jul 14, 2025

[144] Monopar Therapeutics Inc. SEC Filing

Jul 14, 2025

[144] Monopar Therapeutics Inc. SEC Filing

Jul 14, 2025

[144] Monopar Therapeutics Inc. SEC Filing

MNPR Stock Data

Market Cap 247.30M

Float 4.00M

Insiders Ownership 37.31%

Institutions Ownership 42.25%

Short Percent 0.84%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City WILMETTE